{"id":"W4415195696","doi":"10.51731/cjht.2025.1254","title":"Durvalumab (Imfinzi), Carboplatin, Paclitaxel","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Durvalumab; Reimbursement; Paclitaxel; Drug; Cancer; Carboplatin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005648828,0.000190628,0.0003531304,0.0008619989,0.0001588194,0.0006060078,0.0002250024,0.00024179,0.003375566],"category_scores_gemma":[0.001340035,0.00006676152,0.0004041852,0.0009579568,0.000118355,0.000263746,0.0001371483,0.0003652382,0.0004326395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002222234,"about_ca_system_score_gemma":0.002145142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0248415,"about_ca_topic_score_gemma":0.1115939,"domain_scores_codex":[0.9996697,0.00007246476,0.00003885787,0.00003090403,0.0001651266,0.00002291785],"domain_scores_gemma":[0.9996479,0.0001171116,0.0001001439,0.000008389502,0.0001039146,0.00002262726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008737848,0.00004652434,0.001482913,0.007963876,0.0004339799,0.0001408082,0.0000321325,0.0002315279,0.002399819,0.001668174,0.02223056,0.9624958],"study_design_scores_gemma":[0.0007653733,0.0008121656,0.01536331,0.008782354,0.001823144,0.001892993,0.00009579973,0.0003065486,0.004471793,0.0008867934,0.9647766,0.00002305161],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009123667,0.9633757,0.0003998938,0.001461001,0.0001594564,0.000106976,0.0009855261,0.00003549764,0.0243522],"genre_scores_gemma":[0.1273891,0.8532141,0.0030322,0.001677388,0.0001753457,0.000111362,0.001705806,0.00001589222,0.01267886],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0248415,"threshold_uncertainty_score":0.04939377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02021438282566997,"score_gpt":0.3179988967895604,"score_spread":0.2977845139638905,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}